Dr. Zhong Nanshan Professor,Academician, China Academy of Engineering, Director at National Clinical Research Center for Respiratory Disease Dr. Zhong Nanshan Professor,Academician, China Academy of Engineering, Director at National Clinical Research Center for Respiratory Disease
Academician, China Academy of Engineering
Director, National Clinical Research Center for Respiratory Disease Professor Zhong is national leader in the prevention and treatment of major respiratory infectious diseases, chronic obstructive pulmonary disease, bronchial asthma and other respiratory diseases in China. He has published more than 540 international peer-peer papers (Total citations: 10,800, H-index 50), on world’s top medical journals such as NEJM, Lancet, and JAMA. He also published more than 400 papers in national journals sponsored by the Chinese Medical Association; and various monographs <Asthma: From Basic to Clinical>, <Internal Medicine Textbook>, <Respiratory Diseases> he had nearly 60 invention patents. His practical and scientific treatment experience contributed a lot to public health policy shaping of China &Global in every pandemic incident. During the SARS outbreak in 2003, Prof. Zhong opposed the view that typical chlamydia was the cause of SARS. His expertise provided a scientific basis for treatment decision-making in time. Professor Zhong’s team explored "three earlies and three rations" treatment protocol in a short time, namely, early diagnosis, early isolation, early treatment, rational use of corticosteroids, rational use of ventilators, and rational treatment of comorbidities). This protocol contributed to the 3.3% SARS mortality rate in Guangdong, which was the world's lowest SARS mortality rate. Professor Zhong has been leading the development of a number of Chinese guidelines for the diagnosis and management of bronchial asthma, COPD, chronic cough, SARS, highly-pathogenic avian influenza and COVID-19. Since March 2020, Professor Zhong has attended more than thirty international webinar meetings on epidemic prevention and control, including the US, the UK, France, Germany, Italy, Spain, Canada, Japan, Korea, India, Iraq and Nepal. The meetings aimed to share the Chinese experience to help these countries to deal with COVID-19 epidemic. He has also called for greater attention to the spread of novel coronavirus in a number of countries, addressing the importance of implementing the “Four Earlies” principles: early protection, early detection, early diagnosis, and early isolation. In September 2020, he was nominated as a member of COVID-19 Independent Panel for Pandemic Preparedness and Response, WHO. Professor Zhong, shouldering the responsibilities in the outbreak of three coronavirus events this century, has made great efforts in clinical diagnosis, medication, scientific research and governmental strategies. He proposes “One world, one fight” to gather all the resources and strength to fight against the epidemic. Dr. Manson Fok M.B.,B.S.(HK), F.R.C.S.(Edinb), F.C.S.H.K., FHKAM (Surgery); FMAM (Surgery) Dr. Manson Fok M.B.,B.S.(HK), F.R.C.S.(Edinb), F.C.S.H.K., FHKAM (Surgery); FMAM (Surgery)
Dean, Faculty of Medicine, Macau University Science & Technology (MUST)
Chairman, Virtus Medical Group Son of the late Dr. Henry Y.T. Fok, Vice-Chairman of the National committee of the Chinese People’s Political Consultative Conference of the PRC, a well-respected entrepreneur, philanthropist and passionate leader in promoting international sport diplomacy. Professor Manson Fok is a medical doctor married in 1985 with three children currently residing in the Hong Kong SAR. Graduated from the Faculty of Medicine, The University of Hong Kong (1982), Professor Fok is a specialist in minimally invasive surgery for the treatment of esophageal cancers. He is currently the Founding Dean of the Faculty of Medicine, at Macau University Science & Technology (MUST), the first medical school for the Macau SAR. He is also the President of University Hospital at MUST. Professor Fok’s academic titles includes Adjunct Professor, Department Applied Biology & Chemical Technology, The Hong Kong Polytechnic University; Honorary Clinical Associate Professor, Department of Surgery, Faculty of Medicine, The University of Hong Kong; Visiting Professor, Peking University Peoples’ Hospital, PRC; Honorary Professor, Dongzhimen Hospital, Beijing University of Chinese Medicine, PRC; Adjunct Professor, Peking University Cancer Hospital, PRC; etc. Professor Fok assumed Chairmanship and director of Virtus Medical Group, one of the largest all-rounded medical specialist group in Hong Kong & Macau SAR, providing excellent specialist healthcare services to the big bay area of Peoples’ Republic of China (PRC) and beyond. Professor Fok also serve as Director in several medical biotechnology companies in his promotion of medical discovery to address major unmet medical needs, such as cancer and serious infective diseases. He is currently the Chairman of Avalon Biomedical Management (HK); Board directors of Shanghai Pharma, the second largest listed pharmaceutical company in PRC; and in Athenex Inc., an oncology innovation biopharmaceutical company listed in NASDAQ. He is an executive board member of several Foundations, Professional Committees and Medical Associations, including as Censor-in-Chief of World Chinese Doctors’ Association, Honorary Fellow of the Chinese College of Surgeons; Honorary Fellow of Brazil Medical Association; President of Sino-Luso International Medical Forum; President of Macau Healthcare Management and Promotion Association; Executive & Trust Committee member of Macau Henry Fok Foundation; Executive member, Dr. Stanley Ho Medical Development Foundation; and as Professional Committee member, Macau Academy of Medicine; and as committee member of the Council of Medical Affairs of Macau SAR. Over the past seven years, Professor Fok and his team has played a pivoting role in building strong bridges for international cooperation in healthcare education, training and charitable healthcare services, between PRC, the Portuguese speaking countries, and various countries of the Asia-Pacific region. Dr. Billy Chan Director, Center for Education in Medical Simulation, and Executive Assistant to Dean of the Faculty of Medicine at Macau University of Science and Technology Dr. Billy Chan Director, Center for Education in Medical Simulation, and Executive Assistant to Dean of the Faculty of Medicine at Macau University of Science and Technology
Dr Billy C. Chan is currently the dean of Health Sciences at Macau University of Science and Technology (MUST) and Director of the MUST hospital
He is also the Vice Chairman of the Advisory Board at the Macau Healthcare Promotion and Management Association. He is a Standing Committee Member of the International Trauma Rescue and Treatment Association in Beijing, and Honorary Consultant for Peking University Peoples Hospital in Beijing. He is also an Honorary Professor at the First School of Clinical Medicine BUCM, and Executive Council Member of the World Association of Chinese Doctors. For the Portuguese speaking world, he is an Honorary Member of the Brazilian Medical Association, and Honorary Vice President of the Angola Chamber of Commerce in Macao for Medical Affairs. He is also the Co-Founder of Sino-Luso International Medical Forum, promoting healthcare education and skills training between Macau SAR and Portuguese Speaking Countries. Dr Chan is a regionally acknowledged frontrunner in healthcare simulation. Over the past 19 years he has contributed to the arena of medical simulation by introducing skills training programs to advance positive outcomes and reduce errors in the Commonwealth of Australia, New Zealand, Hong Kong SAR, Macao SAR and mainland China. Dr. Harley Seyedin President, AmCham South China Dr. Harley Seyedin President, AmCham South China
Special Advisor, President George H. W. Bush China-U.S. Relations Foundation
Winner of 2017 Oslo Business for Peace Award, Awarded by the Committee of Nobel Laureates in Peace and Economics Among less than 20 individuals to be awarded the Thomas Jefferson Initiated “Peace Through Commerce Medal” by the U.S. Government since its inception in 1790 and the only person in history to have been awarded both the Oslo Business for Peace Award and the Peace Through Commerce Medal. Among 228 individuals from around the world to have been nominated and subsequently shortlisted in March 2016 by the Nobel Committee for consideration for the 2016 Nobel Peace Prize. President, the American Chamber of Commerce in South China President, Allelon Energy Partners Visiting Scholar, Jinan University, PRC In August 2018, Dr. Harley Seyedin was appointed as the Special Advisor to Chairman at President George H. W. Bush China-U.S. Relations Foundation. On March 28, 2017, Dr. Harley Seyedin and Elon Musk won the 2017 Oslo Business for Peace Award. The selection was made by an independent committee of Nobel Prize winners in Peace and Economics in closed-door meetings. The Committee chose the recipients from a pool of nominees from over 40 countries put forward by the United Nations Global Compact (UNGC), the United Nations Development Program (UNDP), and the International Chamber of Commerce (ICC). Each Year, the Business for Peace Award is presented at the end of a two-day celebration entitled “Business for Peace Summit” in May in Oslo, Norway. The ceremony takes place in Oslo City Hall, the same location as that of the Nobel Peace Prize ceremony. In addition to a Welcome Reception and Gala Dinner, hosted by HRH Crown Prince Haakon and HRH Crown Princess Mette-Marit, the Summit also hosts the Business for Peace Roundtable. Some of the confirmed speakers are Norway’s Prime Minister Erna Solberg, Adam Grant (Wharton School of the University of Pennsylvania), Brett Wigdortz (Teach First), George Serafeim (Harvard), Martin Sandbu (Financial Times) and William MacAskill (Oxford). Dr. Harley Seyedin was among 228 individuals from around the world to have been nominated and subsequently shortlisted in March 2016 by the Nobel Committee for consideration for the 2016 Nobel Peace Prize. Other individuals considered include Pope Francis, German Chancellor Angela Merkel, and Columbian President Juan Manuel Santos who was ultimately awarded the prize on October 7, 2016. Dr. Harley Seyedin is the most recent recipient of the "Peace through Commerce Medal" originally initiated by Thomas Jefferson in 1790 when he was the first Secretary of State of the United States. Harley is among less than 20 individuals to receive this Medal in the 228 years since its inception. This Medal is the highest honor awarded to an individual by the U.S. Department of Commerce. Mr. Aaron Finley Director, Central Business Development of Deloitte China Mr. Aaron Finley Director, Central Business Development of Deloitte China
Aaron is a Director in Deloitte’s South China Business Development team based in the Guangzhou office. With a diverse network and broad experience in international business, Aaron helps his clients in developing best practices for international business, accounting, taxation, as well as seek investment and development opportunities. Aaron is also supporting the Deloitte’s Greater Bay Area (GBA) Initiative and is leading the development of a hospital collaboration platform so that hospitals around the GBA can better coordinate best practices. Before re-joining Deloitte, Aaron was the Greater China Group Tax Manager for Procter & Gamble. In 10 years with Procter & Gamble, Aaron performed a multitude of tax and finance roles. Aaron has 20 years of tax experience including 16 years in China.
Aaron is a licensed CPA in California and has obtained a Masters in Business Taxation from the University of Southern California. Aaron is a Part-Time Lecturer and PhD Student at the Macau University of Science & Technology. Aaron was a member of the Board of Directors of the American International School of Guangzhou, the leading international school in South China, from 2010 to 2019. During that time, he served as Treasurer, Vice-Chair, and Chairman of the Board. Aaron is a member of the Board of Governors of AmCham South China. He was recently the EU Chamber of Commerce Finance & Taxation Working Group National Chairman and is currently the Vice Chairman (South China Chapter Chair). He is an Advisor to the Guangdong Investment Promotion Association, an expert of the Guangzhou Capital Market Pool, and a contributor to the Guangzhou City Business Environment Study.